Enabling test script play back in different locales
    34.
    发明授权
    Enabling test script play back in different locales 有权
    启用测试脚本在不同的语言环境中播放

    公开(公告)号:US08938383B2

    公开(公告)日:2015-01-20

    申请号:US11467183

    申请日:2006-08-25

    IPC分类号: G06F17/20 G06F11/36

    CPC分类号: G06F11/3684

    摘要: Apparatus and method for allowing a test script to be played back correctly in a locale of different test language. The invention uses a synonymy dictionary storing the different appearances of the property value of a property in an object of a software product to be tested in different test locales; and compares the property value of the property in the object of the software product to be tested to the corresponding property value pre-recorded in a test script to detect whether they match each other.

    摘要翻译: 允许测试脚本在不同测试语言的区域中正确播放的装置和方法。 本发明使用存储在不同测试区域中要测试的软件产品的对象中的属性的属性值的不同外观的同义字典; 并将要测试的软件产品的对象中的属性的属性值与测试脚本中预先记录的对应属性值进行比较,以检测它们是否相互匹配。

    Power transistor with heat dissipation and method therefor
    35.
    发明授权
    Power transistor with heat dissipation and method therefor 有权
    功率晶体管散热及其方法

    公开(公告)号:US08790964B2

    公开(公告)日:2014-07-29

    申请号:US13538585

    申请日:2012-06-29

    申请人: Min Ding

    发明人: Min Ding

    IPC分类号: H01L21/00

    摘要: A device comprising a substrate, an integrated circuit (IC) die attached to the substrate on one side, a plurality of contact pads on an active side of the IC die, a plurality of thermally and electrically conductive legs, each of the legs attached to a respective one of the contact pads, and an encapsulating material formed around the substrate, the IC die, and a portion of the legs. A contact end of each of the legs is exposed, and one of the contact ends conducts a signal from a transistor in the IC die.

    摘要翻译: 一种器件,包括衬底,在一侧附着到衬底的集成电路(IC)裸片,在IC管芯的有源侧上的多个接触焊盘,多个导热和导电的腿,每个腿连接到 接触焊盘中的相应一个,以及围绕该基板,IC芯片和一部分腿形成的封装材料。 每个腿的接触端被暴露,并且一个接触端传导来自IC管芯中的晶体管的信号。

    System and method for determining application dependency paths in a data center
    37.
    发明授权
    System and method for determining application dependency paths in a data center 有权
    用于确定数据中心中的应用程序依赖路径的系统和方法

    公开(公告)号:US08443080B2

    公开(公告)日:2013-05-14

    申请号:US13100805

    申请日:2011-05-04

    IPC分类号: G06F15/173

    摘要: A method and a system are disclosed for determining application dependency paths in a data center. The method and the system captures application traffic volume data on the servers with switches and monitoring agents; generates an application traffic matrix of all the components of the applications based on the application traffic volume data; estimates the number of the applications in the data center from the traffic matrix with a Rank Estimation via Singular Value Decomposition or Power Factorization Residue Errors process; and decomposes the traffic matrix into a first matrix and a second matrix with a non-negative matrix factorization process using the estimated number of applications. The first matrix represents a set of the components belonging to each of the applications and the second matrix represents the amount of traffic generated by each application over time. Any noise in the first and second matrices is removed with a concurrent volumes ratios based correlation process.

    摘要翻译: 公开了一种用于确定数据中心中的应用依赖路径的方法和系统。 该方法和系统使用交换机和监控代理在服务器上捕获应用程序流量数据; 基于应用业务量数据生成应用的所有组件的应用业务矩阵; 通过奇异值分解或功率因子分解残差错误进行等级估计从业务矩阵估计数据中心中的应用数量; 并且使用估计的应用数量将业务矩阵分解为第一矩阵和具有非负矩阵分解过程的第二矩阵。 第一矩阵表示属于每个应用的组件的集合,第二矩阵表示每个应用随时间生成的流量。 第一和第二矩阵中的任何噪声均以基于并发卷比的相关过程被去除。

    Pharmaceutical compositions and methods for stabilizing the same
    40.
    发明申请
    Pharmaceutical compositions and methods for stabilizing the same 审中-公开
    药物组合物及其稳定方法

    公开(公告)号:US20100105743A1

    公开(公告)日:2010-04-29

    申请号:US12462147

    申请日:2009-07-30

    IPC分类号: A61K31/44 A61P9/12

    摘要: Pharmaceutical compositions, and a method of stabilizing pharmaceutical compositions having clevidipine, or any pharmaceutically acceptable salt thereof, as the active ingredient is described. The method includes the slowing down or inhibiting of the oxidation pathway of clevidipine. This can be accomplished by reducing the amount the pharmaceutical composition is exposed to oxygen and/or light during the manufacturing and storing processes. According to this method, oxygen must be removed or replaced, or light must be sufficiently blocked such that light energy cannot reach the active ingredient of the composition, or is reduced to a level that the light-induced oxidation reaction converting clevidipine to H324/78 is minimized, such that the total detectable level of H324/78 in a given composition sample does not exceed about 0.2% on a weight-by-weight basis, or the ratio of clevidipine to H324/78 is equal to or greater than about 450 to 1 on a weight-to-weight basis.

    摘要翻译: 描述了药物组合物和稳定具有氯维地平的药物组合物或其任何药学上可接受的盐作为活性成分的方法。 该方法包括减缓或抑制氯维地平的氧化途径。 这可以通过在制造和储存过程中减少药物组合物暴露于氧和/或光的量来实现。 根据该方法,必须除去或更换氧气,或者必须充分阻挡光,使得光能不能达到组合物的活性成分,或者降低到光诱导的氧化反应将氯维地平转化为H324 / 78 被最小化,使得给定组合物样品中H324 / 78的总可检测水平以重量计不超过约0.2%,或者氯维地平与H324 / 78的比例等于或大于约450 至1,以重量为基准。